Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease

One third of patients with inflammatory bowel disease (IBD) inadequately respond to anti-TNF treatment and preclinical data suggest that matrix metalloproteinase-9 (MMP-9) is a novel therapeutic target. Here we show that IBD clinical and histopathological parameters found in wild type mice challenge...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Nat Commun
Asıl Yazarlar: de Bruyn, Magali, Breynaert, Christine, Arijs, Ingrid, De Hertogh, Gert, Geboes, Karel, Thijs, Greet, Matteoli, Gianluca, Hu, Jialiang, Van Damme, Jo, Arnold, Bernd, Ferrante, Marc, Vermeire, Séverine, Van Assche, Gert, Opdenakker, Ghislain
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5460016/
https://ncbi.nlm.nih.gov/pubmed/28561062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms15384
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller